IL2RA and COVID-19: In addition, the serum IL-2R level was found to be significantly higher in patients with severe COVID-19 than in patients without severe disease (1185 ± 80 U/ml vs 631 ± 37 U/ml) (32, 33), suggesting that serum IL-2R may also play a role in predicting the severity and prognosis of COVID-19.